Dupliumab therapy for alopecia areata: a case series and review of the literature
Background A growing body of research supports the important role of the TH2 axis in alopecia areata (AA). Dupilumab is a humanized monoclonal antibody against IL-4Rα that downregulates TH2 response. Although efficacy has been shown in clinical trials, real-world data on the use of dupilumab in AA p...
Saved in:
| Main Authors: | Jundong Huang, Jia Jian, Tingting Li, Min Li, Kaifu Luo, Sihan Deng, Yan Tang, Fangfen Liu, Zhixiang Zhao, Wei Shi, Ji Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Journal of Dermatological Treatment |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09546634.2024.2312245 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dupilumab for the treatment of atopic dermatitis and alopecia areata with incidental improvement of trachyonychia
by: Dana H. Chung, BA, et al.
Published: (2025-09-01) -
Alopecia Areata Associated with Dupilumab: National Database Study
by: Tarun Sontam, et al.
Published: (2025-07-01) -
Successful Dupilumab Administration in Adolescent with Alopecia Areata and Atopic Dermatitis: Clinical Case
by: Eduard T. Ambarchyan, et al.
Published: (2024-09-01) -
Successful treatment of a case of dupilumab-induced psoriasis and alopecia areata with tofacitinib
by: SUN Feifei, et al.
Published: (2025-06-01) -
Case Report: Severe ophiasis-pattern alopecia areata with concomitant atopic dermatitis in a 5-year-old boy successfully treated with dupilumab
by: Zhendong Wei, et al.
Published: (2025-02-01)